C. Logothetis

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

Eugene D. Kwon, Charles G. Drake, H. I. Scher et al. · The Lancet Oncology · 2014 · 1.5K citations · Full text

Urology, Oncology, Docetaxel Chemotherapy +9

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.

C. Logothetis, F. H. Dexeus, Laura Finn et al. · Journal of Clinical Oncology · 1990 · 616 citations

Urological Research, Urology, Genitourinary Cancer +15

Effects of Blocking Platelet-Derived Growth Factor-Receptor Signaling in a Mouse Model of Experimental Prostate Cancer Bone Metastases

Hisanori Uehara, Seung Jun Kim, Takashi Karashima et al. · JNCI Journal of the National Cancer Institute · 2003 · 278 citations · Full text

Altered Expression of Retinoblastoma Protein and Known Prognostic Variables in Locally Advanced Bladder Cancer

C. Logothetis, Hang Xu, J Y Ro et al. · JNCI Journal of the National Cancer Institute · 1992 · 251 citations

Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.

C. Logothetis, Douglas E. Johnson, Clayton Chong et al. · Journal of Clinical Oncology · 1988 · 164 citations

Surgical Oncology, Cancer Management, Adjuvant Chemotherapy +19